|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Investment owned at fair value | |||||||||||||||||
| Non-Controlled/Affliate Investments | |||||||||||||||||
| Non Controlled Non Affiliate Investments | |||||||||||||||||
| Non Controlled Affiliate Investments | |||||||||||||||||
| Controlled Investments | |||||||||||||||||
| Non-controlled/non-affiliate investments | |||||||||||||||||
| Non-controlled/affiliate investments | |||||||||||||||||
| Total investment owned at fair value | |||||||||||||||||
| Investments in U.S. Treasury bills (cost of $29,245,079 and $63,792,704, respectively) | |||||||||||||||||
| Investments in U.S. Treasury bills (cost of $0 and $63,792,704, respectively) | |||||||||||||||||
| Total Investments (cost of $256,809,654 and $276,333,902, respectively) | |||||||||||||||||
| Cash | |||||||||||||||||
| Proceeds receivable | |||||||||||||||||
| Restricted cash | |||||||||||||||||
| Escrow proceeds receivable | |||||||||||||||||
| Interest and dividends receivable | |||||||||||||||||
| Deferred financing costs | |||||||||||||||||
| Prepaid expenses and other assets | |||||||||||||||||
| Total Assets | |||||||||||||||||
| LIABILITIES | |||||||||||||||||
| 6.00% Notes due December 30, 2026 | |||||||||||||||||
| 6.50% Convertible Notes due August 14, 2029 | |||||||||||||||||
| 6.50% Redeemable Promissory Note due July 16, 2029 | |||||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||||
| Accrued management fees | |||||||||||||||||
| Accrued interest payable | |||||||||||||||||
| Dividends payable | |||||||||||||||||
| Total Liabilities | |||||||||||||||||
| Net Assets | |||||||||||||||||
| Common stock, par value $0.01 per share (100,000,000 authorized; 26,473,222 and 25,377,756 issued and outstanding, respectively) | |||||||||||||||||
| Paid-in capital in excess of par | |||||||||||||||||
| Accumulated net investment loss | |||||||||||||||||
| Accumulated net realized gain on investments, net of distributions | |||||||||||||||||
| Accumulated net unrealized appreciation/(depreciation) of investments | |||||||||||||||||
| Net Asset Value Per Share | |||||||||||||||||
Loading...